31 results
Page 2 of 2
8-K
EX-2.1
ffh7b eqkxnfefilh
21 Dec 20
EyeGate Pharma Announces Transformative Acquisition of Panoptes Pharma
6:55am
8-K
EX-10.1
prlkxrh1 cyf
31 Dec 19
EyeGate Announces $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:05pm
8-K
EX-10.1
7896 lysvi
30 Sep 19
EyeGate Enters Into Agreement for $1.9 Million Private Placement
6:55am
8-K
EX-10.2
9a0jh9eu ot289rj0
30 Sep 19
EyeGate Enters Into Agreement for $1.9 Million Private Placement
6:55am
PRE 14A
pf0fyj1e8cpbzdmj d4
17 May 18
Preliminary proxy
5:21pm
8-K
EX-10.1
u8hbeabe8q2q7z
13 Apr 18
EyeGate Announces $11.25 Million Public Offering
12:00am
8-K
EX-3.2
xaianoki81p
20 Feb 15
Amendments to Articles of Incorporation or Bylaws
12:00am
DRS/A
EX-3.4
6wn7 v1g0ndsf8te
8 Jul 14
Draft registration statement (amended)
12:00am